Pathological Gambling Clinical Trial
Official title:
Effectiveness of Cognitive-Motivational Behaviour Therapy in Community
The efficacy of psychosocial treatments for PG, including cognitive-behaviour therapy (CBT) and motivational interviewing (MI) approaches, has been supported in a handful of clinical trials. Indeed, there is more evidence supporting these two approaches than for any other psychosocial treatment for problem gambling. However, while efficacy studies have been conducted, few studies have examined the effectiveness of behavioural treatment in community-based gambling treatment settings. That is to say, the investigators have a good idea of what works in a laboratory setting (i.e., university research settings), but the investigators have no research assessing the transfer of evidence-based treatments for problem gambling to community care. Efficacy studies provide substantially less information about the actual utility of treatments than do effectiveness trials because the way in which treatment is actually provided in the field (with flexibility in terms of time-frame and technique and the tendency to address co-occurring problems) is different from the much more single-focused (on gambling) way it is conducted in laboratory settings. The proposed study is designed to address this significant gap in the research literature. The investigators propose to conduct a treatment effectiveness trial examining a combined cognitive motivational behavior therapy (CMBT) delivered by community-based problem gambling treatment providers, compared with treatment as usual (TAU).
Pilot Study: Eligible participants will undergo a full consent process and a brief interview
to assess demographics. Participants' counselors will be asked to audio-record up to 3
therapy sessions which will subsequently be rated for adherence to CMBT procedures.
Main Study: Eligible participants will undergo a full consent process followed by an
in-depth interview, with a research assistant. Following an intake assessment, participants
will be randomly assigned to one of the three intervention groups. Randomization also will
be balanced based on gender to ensure an equitable distribution of men and women in each
condition. The research assistant will give the treatment referrals and will introduce the
participant to his/her therapist as appropriate.
Treatment will be provided by clinicians at the Windsor Regional Problem Gambling Services.
- Treatment as usual (TAU) - Therapists will be instructed to conduct therapy as they
normally would with PGs entering treatment.
- Cognitive motivational behaviour therapy (CMBT) Therapy will consist of 12 60-minute
individual counselling sessions. The cognitive-behavioural portion of the intervention
is targeted at addressing gambling-related cognitive distortions (e.g., the idea that
the gambler can control random events). Motivational interviewing techniques are
included to address participant ambivalence about his/her gambling.
Approximately 8 therapists will provide treatment (4 CMBT and 4 TAU, randomly assigned using
flip of a coin.) The therapists enrolled in CMBT will be trained for the study. TAU
therapists will be offered training in CMBT once study recruitment goals have been met
(thus, eventually all therapists will receive training in CMBT). Prior to providing
treatment, therapists selected to administer CMBT will receive intensive training in
administration of this approach. The therapists will be selected from the professional staff
of the Windsor Regional Hospital's Problem Gambling Services.
-Waitlist control condition (WLC) - WLC participants will wait 12-weeks to begin treatment.
At that point, participants will be randomly assigned to receive TAU or CMBT and will
proceed through the same study phase (i.e., treatment and follow-up).
Participants will undergo assessments at intake, post-treatment, 6- and 12-months.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02590211 -
Poker, Skills and Associated Problems
|
N/A | |
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 |